Lloyds Buys Bharat Wire Ropes Stake; Ind-Swift Labs Sees Major Sell-Off

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorAditi Singh|Published at:
Lloyds Buys Bharat Wire Ropes Stake; Ind-Swift Labs Sees Major Sell-Off
Overview

Lloyds Group companies boosted their stake in Bharat Wire Ropes by over 5% through open market purchases on April 17, propelling the wire rope manufacturer's shares up by 20%. Concurrently, HCP Investments divested a significant 5.53% holding in Ind-Swift Laboratories, leading to a 9.32% drop in the pharma firm's stock. Smaller transactions also occurred in Anzen India Energy Yield Plus Trust.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Lloyds Group Boosts Bharat Wire Ropes Holding

Lloyds Group entities made substantial open market purchases in Bharat Wire Ropes on April 17, acquiring a cumulative 5.31% equity stake for approximately ₹74.11 crore. Lloyds Metals and Energy picked up 20 lakh shares at ₹193.42 each, while its affiliate Lloyds Enterprises bought a combined 16.46 lakh shares at prices ranging from ₹215 to ₹215.17 per share. This strategic accumulation immediately impacted market sentiment.

Bharat Wire Ropes Shares Hit Upper Circuit

The news of the increased stake by Lloyds Group sent Bharat Wire Ropes shares soaring 20%, hitting the upper circuit for the first time since late October 2025. The stock closed at ₹221.96, its highest level since July 10, 2025, signaling strong investor confidence following the bulk deal. In a counter-move, Resonance Opportunities Fund divested 2.48% of its stake in the company at ₹193 per share.

HCP Investments Divests Ind-Swift Labs Stake

Simultaneously, HCP Investments continued its sell-off in Ind-Swift Laboratories, offloading an additional 5.53% equity stake for ₹64.4 crore. Shares of the pharmaceutical firm declined sharply by 9.32%, closing at ₹131.86 on the National Stock Exchange. This latest transaction follows a previous sale of 1.12%, bringing HCP Investments' total divestment over two days to 6.65% of its original shareholding.

Other Notable Transactions

In separate dealings, Sahastraa Advisors acquired 4.75 lakh shares in Ind-Swift Laboratories at ₹131.74 each, and Nova Global Opportunities Fund PCC - Touchstone purchased 8.03 lakh shares at ₹138.07. Prazim Trading and Investment Company also bought 32 lakh units in Anzen India Energy Yield Plus Trust at ₹125 per unit, valued at ₹40 crore, while Famy Steri sold units in the same trust.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.